These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1522 related items for PubMed ID: 19678745

  • 1. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
    Romão R, Rubio IG, Tomimori EK, Camargo RY, Knobel M, Medeiros-Neto G.
    Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of administering 0.2 mg of recombinant human TSH for two consecutive days as an adjuvant to therapy with low radioiodine doses in elderly out-patients with large nontoxic multinodular goiter.
    Giusti M, Cappi C, Santaniello B, Ceresola E, Augeri C, Lagasio C, Minuto F.
    Minerva Endocrinol; 2006 Sep; 31(3):191-209. PubMed ID: 17213787
    [Abstract] [Full Text] [Related]

  • 3. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres.
    Silva MN, Rubió IG, Romão R, Gebrin EM, Buchpiguel C, Tomimori E, Camargo R, Cardia MS, Medeiros-Neto G.
    Clin Endocrinol (Oxf); 2004 Mar; 60(3):300-8. PubMed ID: 15008994
    [Abstract] [Full Text] [Related]

  • 4. Single, very low dose (0.03 mg) of recombinant human thyrotropin (rhTSH) effectively increases radioiodine uptake in the I-131 treatment of large nontoxic multinodular goiter.
    Mojsak MN, Abdelrazek S, Szumowski P, Rogowski F, Sykała M, Kostecki J, Kociura-Sawicka A, Jurgilewicz D, Myśliwiec J.
    Nucl Med Rev Cent East Eur; 2016 Mar; 19(1):3-11. PubMed ID: 26841373
    [Abstract] [Full Text] [Related]

  • 5. Radioiodine 131I treatment for large nodular goiter: recombinant human thyrotropin allows the reduction of radioiodine 131I activity to be administered in patients with low uptake.
    Ceccarelli C, Antonangeli L, Brozzi F, Bianchi F, Tonacchera M, Santini P, Mazzeo S, Bencivelli W, Pinchera A, Vitti P.
    Thyroid; 2011 Jul; 21(7):759-64. PubMed ID: 21568727
    [Abstract] [Full Text] [Related]

  • 6. Recombinant human TSH increases the efficacy of a fixed activity of radioiodine for treatment of multinodular goitre.
    Cubas ER, Paz-Filho GJ, Olandoski M, Goedert CA, Woellner LC, Carvalho GA, Graf H.
    Int J Clin Pract; 2009 Apr; 63(4):583-90. PubMed ID: 18803554
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome.
    Walter MA, Christ-Crain M, Eckard B, Schindler C, Nitzsche EU, Müller-Brand J, Müller B.
    Eur J Clin Invest; 2004 May; 34(5):365-70. PubMed ID: 15147334
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S, Jaatinen P, Huhtala H, Luukkaala T, Oksala H, Salmi J.
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cardiovascular assessment of hyperthyroid patients with multinodular goiter before and after radioiodine treatment preceded by stimulation with recombinant human TSH.
    Barca MF, Gruppi C, Oliveira MT, Romão R, Cárdia MS, Rubio I, Knobel M, Medeiros-Neto G.
    Endocrine; 2007 Oct; 32(2):175-81. PubMed ID: 18026694
    [Abstract] [Full Text] [Related]

  • 15. Human recombinant TSH preceding a therapeutic dose of radioiodine for multinodular goiters has no significant effect in the surge of TSH-receptor and TPO antibodies.
    Rubio IG, Perone BH, Silva MN, Knobel M, Medeiros-Neto G.
    Thyroid; 2005 Feb; 15(2):134-9. PubMed ID: 15753672
    [Abstract] [Full Text] [Related]

  • 16. Peripheral blood levels of thyroglobulin mRNA and serum thyroglobulin concentrations after radioiodine ablation of multinodular goiter with or without pre-treatment with recombinant human thyrotropin.
    Rubio IG, Silva MN, Knobel M, Romão R, Possato R, Gebrin EM, Buchpiguel C, Medeiros-Neto G.
    J Endocrinol Invest; 2007 Feb; 30(7):535-40. PubMed ID: 17848834
    [Abstract] [Full Text] [Related]

  • 17. Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study.
    Taïeb D, Sebag F, Cherenko M, Baumstarck-Barrau K, Fortanier C, Farman-Ara B, De Micco C, Vaillant J, Thomas S, Conte-Devolx B, Loundou A, Auquier P, Henry JF, Mundler O.
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):115-23. PubMed ID: 18803678
    [Abstract] [Full Text] [Related]

  • 18. A 30-year perspective on radioiodine therapy of benign nontoxic multinodular goiter.
    Bonnema SJ, Hegedüs L.
    Curr Opin Endocrinol Diabetes Obes; 2009 Oct; 16(5):379-84. PubMed ID: 19623060
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 77.